CommercialCoverageMedium impact
11.17.06s, Surgical and Minimally Invasive Treatments for Urinary Outlet Obstruction due to Benign Prostatic Hyperplasia (BPH)
Independence Blue Cross·Urology·Medical Policy
Effective date
Jan 1, 2025
We identified it
Jun 19, 2026
Summary
Policy 11.17.06s regarding surgical and minimally invasive treatments for urinary outlet obstruction due to benign prostatic hyperplasia (BPH) has been updated for commercial plans. This policy affects coverage criteria and treatment guidelines for BPH procedures.
Action Required
By January 31, 2025: Billing team should review the full policy document at the provided URL to understand specific coverage changes for BPH treatments. Urology providers should verify current prior authorization requirements and documentation standards for BPH surgical procedures under commercial plans.